Phase 2b Prader-Willi Syndrome Trial Ends in Disappointment
source: pixabay.com

Phase 2b Prader-Willi Syndrome Trial Ends in Disappointment

According to a story from Malvern Daily Record, the biopharmaceutical company Millendo Therapeutics, Inc. recently released data from its phase 2b clinical trial. This study was testing the company's experimental…

Continue Reading Phase 2b Prader-Willi Syndrome Trial Ends in Disappointment
Could This Experimental Drug Treat Extreme Hunger in Prader-Willi Syndrome?
source: pixabay.com

Could This Experimental Drug Treat Extreme Hunger in Prader-Willi Syndrome?

According to a story from labblog.uofmhealth.org, one of the defining features of Prader-Willi syndrome, a rare disorder, is hyperphagia, which is extreme overeating and obsession with food. While this is…

Continue Reading Could This Experimental Drug Treat Extreme Hunger in Prader-Willi Syndrome?
Updates on Phase 3 Prader-Willi Syndrome Trial Indicate Positive Results so Far
geralt / Pixabay

Updates on Phase 3 Prader-Willi Syndrome Trial Indicate Positive Results so Far

According to a story from Financial Buzz, the biopharmaceutical company Soleno Therapeutics recently provided an update on the progress of the Company's Phase 3 clinical trial. This trial is evaluating…

Continue Reading Updates on Phase 3 Prader-Willi Syndrome Trial Indicate Positive Results so Far

Residential Care for Prader-Willi Syndrome? This Celebrity is Considering It

According to a story from metro.co.uk, celebrity Katie Price, an English television personality, author, singer, and designer is reportedly considering part time residential care for her son Harvey. Harvey has…

Continue Reading Residential Care for Prader-Willi Syndrome? This Celebrity is Considering It
Phase 2a Prader-Willi Syndrome Trial Enters Open-Label Extension
stevepb / Pixabay

Phase 2a Prader-Willi Syndrome Trial Enters Open-Label Extension

According to a story from finanznachrichten.de, the biotechnology company Saniona recently announced that its treatment period for adolescent patients in its Phase 2a clinical trial testing Tesomet as a treatment for…

Continue Reading Phase 2a Prader-Willi Syndrome Trial Enters Open-Label Extension
Extension Study for Prader-Willi Syndrome Initiated After Completion of Phase 2a Trial
source: pixabay.com

Extension Study for Prader-Willi Syndrome Initiated After Completion of Phase 2a Trial

Prader-Willi Syndrome (PWS) is caused by deleted genes on chromosome 15. This results in improper signaling of satiety, leading to obesity. Individuals with the condition can suffer from respiratory/cardiac disease, gastric…

Continue Reading Extension Study for Prader-Willi Syndrome Initiated After Completion of Phase 2a Trial
New Phase 3 Trial for Prader-Willi Syndrome is now Enrolling Patients
Source: Pixabay.com

New Phase 3 Trial for Prader-Willi Syndrome is now Enrolling Patients

Prader-Willi syndrome (PWS) is a neurodevelopmental disorder which causes intellectual disability, a deficiency of growth hormones, compulsive behavior, a high risk of obesity, and hyperphagia, a symptom which can be…

Continue Reading New Phase 3 Trial for Prader-Willi Syndrome is now Enrolling Patients
Positive Results from Safety Trial of CBD for Refractory Pediatric Epilepsy
Source: pixabay.com

Positive Results from Safety Trial of CBD for Refractory Pediatric Epilepsy

INSYS Therapeutics has just released data from their long-term safety study of CBD as a treatment for refractory pediatric epilepsy. The results were positive and we're excited about the future…

Continue Reading Positive Results from Safety Trial of CBD for Refractory Pediatric Epilepsy
Part Two of Phase 2 Prader-Willi Syndrome Trial Has Reached Recruitment Goal
andibreit / Pixabay

Part Two of Phase 2 Prader-Willi Syndrome Trial Has Reached Recruitment Goal

According to a story from PR-Inside, the biotechnology company Saniona recently announced that the second part of its Phase 2a clinical trial testing Tesomet as a treatment for Prader-Willi syndrome…

Continue Reading Part Two of Phase 2 Prader-Willi Syndrome Trial Has Reached Recruitment Goal
Phase III Prader-Willi Syndrome Clinical Trial to be Expanded to Include Younger Patients
RyanMcGuire / Pixabay

Phase III Prader-Willi Syndrome Clinical Trial to be Expanded to Include Younger Patients

According to a story from BioSpace, the biopharmaceutical company Soleno Therapeutics recently announced that it will be updating the minimum age for participating patients in its Phase III clinical trial…

Continue Reading Phase III Prader-Willi Syndrome Clinical Trial to be Expanded to Include Younger Patients
Possible Treatment for Hypothalamic Obesity and Prader-Willi Syndrome Will be Tested in Phase 2 Trial
mohamed_hassan / Pixabay

Possible Treatment for Hypothalamic Obesity and Prader-Willi Syndrome Will be Tested in Phase 2 Trial

According to a story from GlobeNewswire, the biotech company Saniona has recently announced plans to begin the design and initiation of a Phase 2a clinical trial study of its investigational…

Continue Reading Possible Treatment for Hypothalamic Obesity and Prader-Willi Syndrome Will be Tested in Phase 2 Trial
Cannabidiol Oral Solution Granted Fast Track Application for Prader-Willi Syndrome
Source: Pixabay

Cannabidiol Oral Solution Granted Fast Track Application for Prader-Willi Syndrome

Prader-Willi syndrome is a rare condition which causes the body to feel insatiable hunger, regardless of how much a patient eats. Treatment options are currently inadequate for many patients. Today,…

Continue Reading Cannabidiol Oral Solution Granted Fast Track Application for Prader-Willi Syndrome
Close Menu